Medical Care
Global Antifungal Microbial Drugs Market Research Report 2025
- May 12, 25
- ID: 236327
- Pages: 100
- Figures: 100
- Views: 1
The global market for Antifungal Microbial Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Antifungal Microbial Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antifungal Microbial Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antifungal Microbial Drugs include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, AOBiome, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antifungal Microbial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal Microbial Drugs.
The Antifungal Microbial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antifungal Microbial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antifungal Microbial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Segment by Type
Oral Dosage Form
Enteric Capsules
Segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antifungal Microbial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antifungal Microbial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Antifungal Microbial Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antifungal Microbial Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antifungal Microbial Drugs include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, AOBiome, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antifungal Microbial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal Microbial Drugs.
The Antifungal Microbial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antifungal Microbial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antifungal Microbial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Segment by Type
Oral Dosage Form
Enteric Capsules
Segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antifungal Microbial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antifungal Microbial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Antifungal Microbial Drugs Market Overview
1.1 Product Definition
1.2 Antifungal Microbial Drugs by Type
1.2.1 Global Antifungal Microbial Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Antifungal Microbial Drugs by Application
1.3.1 Global Antifungal Microbial Drugs Market Value by Application (2024 VS 2031)
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Global Antifungal Microbial Drugs Market Size Estimates and Forecasts
1.4.1 Global Antifungal Microbial Drugs Revenue 2020-2031
1.4.2 Global Antifungal Microbial Drugs Sales 2020-2031
1.4.3 Global Antifungal Microbial Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antifungal Microbial Drugs Market Competition by Manufacturers
2.1 Global Antifungal Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antifungal Microbial Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antifungal Microbial Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antifungal Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antifungal Microbial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antifungal Microbial Drugs, Product Type & Application
2.7 Global Key Manufacturers of Antifungal Microbial Drugs, Date of Enter into This Industry
2.8 Global Antifungal Microbial Drugs Market Competitive Situation and Trends
2.8.1 Global Antifungal Microbial Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antifungal Microbial Drugs Players Market Share by Revenue
2.8.3 Global Antifungal Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antifungal Microbial Drugs Market Scenario by Region
3.1 Global Antifungal Microbial Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antifungal Microbial Drugs Sales by Region: 2020-2031
3.2.1 Global Antifungal Microbial Drugs Sales by Region: 2020-2025
3.2.2 Global Antifungal Microbial Drugs Sales by Region: 2026-2031
3.3 Global Antifungal Microbial Drugs Revenue by Region: 2020-2031
3.3.1 Global Antifungal Microbial Drugs Revenue by Region: 2020-2025
3.3.2 Global Antifungal Microbial Drugs Revenue by Region: 2026-2031
3.4 North America Antifungal Microbial Drugs Market Facts & Figures by Country
3.4.1 North America Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antifungal Microbial Drugs Sales by Country (2020-2031)
3.4.3 North America Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antifungal Microbial Drugs Market Facts & Figures by Country
3.5.1 Europe Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antifungal Microbial Drugs Sales by Country (2020-2031)
3.5.3 Europe Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antifungal Microbial Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Antifungal Microbial Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antifungal Microbial Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Antifungal Microbial Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antifungal Microbial Drugs Market Facts & Figures by Country
3.7.1 Latin America Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antifungal Microbial Drugs Sales by Country (2020-2031)
3.7.3 Latin America Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antifungal Microbial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antifungal Microbial Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antifungal Microbial Drugs Sales by Type (2020-2031)
4.1.1 Global Antifungal Microbial Drugs Sales by Type (2020-2025)
4.1.2 Global Antifungal Microbial Drugs Sales by Type (2026-2031)
4.1.3 Global Antifungal Microbial Drugs Sales Market Share by Type (2020-2031)
4.2 Global Antifungal Microbial Drugs Revenue by Type (2020-2031)
4.2.1 Global Antifungal Microbial Drugs Revenue by Type (2020-2025)
4.2.2 Global Antifungal Microbial Drugs Revenue by Type (2026-2031)
4.2.3 Global Antifungal Microbial Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Antifungal Microbial Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antifungal Microbial Drugs Sales by Application (2020-2031)
5.1.1 Global Antifungal Microbial Drugs Sales by Application (2020-2025)
5.1.2 Global Antifungal Microbial Drugs Sales by Application (2026-2031)
5.1.3 Global Antifungal Microbial Drugs Sales Market Share by Application (2020-2031)
5.2 Global Antifungal Microbial Drugs Revenue by Application (2020-2031)
5.2.1 Global Antifungal Microbial Drugs Revenue by Application (2020-2025)
5.2.2 Global Antifungal Microbial Drugs Revenue by Application (2026-2031)
5.2.3 Global Antifungal Microbial Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Antifungal Microbial Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Company Information
6.1.2 Seres Therapeutics Description and Business Overview
6.1.3 Seres Therapeutics Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seres Therapeutics Antifungal Microbial Drugs Product Portfolio
6.1.5 Seres Therapeutics Recent Developments/Updates
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Company Information
6.2.2 Assembly Biosciences Description and Business Overview
6.2.3 Assembly Biosciences Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Assembly Biosciences Antifungal Microbial Drugs Product Portfolio
6.2.5 Assembly Biosciences Recent Developments/Updates
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Company Information
6.3.2 Synthetic Biologics Description and Business Overview
6.3.3 Synthetic Biologics Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synthetic Biologics Antifungal Microbial Drugs Product Portfolio
6.3.5 Synthetic Biologics Recent Developments/Updates
6.4 Interxon
6.4.1 Interxon Company Information
6.4.2 Interxon Description and Business Overview
6.4.3 Interxon Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Interxon Antifungal Microbial Drugs Product Portfolio
6.4.5 Interxon Recent Developments/Updates
6.5 PureTech
6.5.1 PureTech Company Information
6.5.2 PureTech Description and Business Overview
6.5.3 PureTech Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PureTech Antifungal Microbial Drugs Product Portfolio
6.5.5 PureTech Recent Developments/Updates
6.6 Synlogic
6.6.1 Synlogic Company Information
6.6.2 Synlogic Description and Business Overview
6.6.3 Synlogic Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synlogic Antifungal Microbial Drugs Product Portfolio
6.6.5 Synlogic Recent Developments/Updates
6.7 Enterome BioScience
6.7.1 Enterome BioScience Company Information
6.7.2 Enterome BioScience Description and Business Overview
6.7.3 Enterome BioScience Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enterome BioScience Antifungal Microbial Drugs Product Portfolio
6.7.5 Enterome BioScience Recent Developments/Updates
6.8 4D Pharma
6.8.1 4D Pharma Company Information
6.8.2 4D Pharma Description and Business Overview
6.8.3 4D Pharma Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 4D Pharma Antifungal Microbial Drugs Product Portfolio
6.8.5 4D Pharma Recent Developments/Updates
6.9 Second Genome
6.9.1 Second Genome Company Information
6.9.2 Second Genome Description and Business Overview
6.9.3 Second Genome Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Second Genome Antifungal Microbial Drugs Product Portfolio
6.9.5 Second Genome Recent Developments/Updates
6.10 AOBiome
6.10.1 AOBiome Company Information
6.10.2 AOBiome Description and Business Overview
6.10.3 AOBiome Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AOBiome Antifungal Microbial Drugs Product Portfolio
6.10.5 AOBiome Recent Developments/Updates
6.11 Rebiotix
6.11.1 Rebiotix Company Information
6.11.2 Rebiotix Description and Business Overview
6.11.3 Rebiotix Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rebiotix Antifungal Microbial Drugs Product Portfolio
6.11.5 Rebiotix Recent Developments/Updates
6.12 Metabiomics
6.12.1 Metabiomics Company Information
6.12.2 Metabiomics Description and Business Overview
6.12.3 Metabiomics Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Metabiomics Antifungal Microbial Drugs Product Portfolio
6.12.5 Metabiomics Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Company Information
6.13.2 Ritter Pharmaceuticals Description and Business Overview
6.13.3 Ritter Pharmaceuticals Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ritter Pharmaceuticals Antifungal Microbial Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Symberix
6.14.1 Symberix Company Information
6.14.2 Symberix Description and Business Overview
6.14.3 Symberix Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Symberix Antifungal Microbial Drugs Product Portfolio
6.14.5 Symberix Recent Developments/Updates
6.15 OpenBiome
6.15.1 OpenBiome Company Information
6.15.2 OpenBiome Description and Business Overview
6.15.3 OpenBiome Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 OpenBiome Antifungal Microbial Drugs Product Portfolio
6.15.5 OpenBiome Recent Developments/Updates
6.16 Azitra
6.16.1 Azitra Company Information
6.16.2 Azitra Description and Business Overview
6.16.3 Azitra Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Azitra Antifungal Microbial Drugs Product Portfolio
6.16.5 Azitra Recent Developments/Updates
6.17 Osel
6.17.1 Osel Company Information
6.17.2 Osel Description and Business Overview
6.17.3 Osel Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Osel Antifungal Microbial Drugs Product Portfolio
6.17.5 Osel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antifungal Microbial Drugs Industry Chain Analysis
7.2 Antifungal Microbial Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antifungal Microbial Drugs Production Mode & Process Analysis
7.4 Antifungal Microbial Drugs Sales and Marketing
7.4.1 Antifungal Microbial Drugs Sales Channels
7.4.2 Antifungal Microbial Drugs Distributors
7.5 Antifungal Microbial Drugs Customer Analysis
8 Antifungal Microbial Drugs Market Dynamics
8.1 Antifungal Microbial Drugs Industry Trends
8.2 Antifungal Microbial Drugs Market Drivers
8.3 Antifungal Microbial Drugs Market Challenges
8.4 Antifungal Microbial Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Antifungal Microbial Drugs by Type
1.2.1 Global Antifungal Microbial Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Antifungal Microbial Drugs by Application
1.3.1 Global Antifungal Microbial Drugs Market Value by Application (2024 VS 2031)
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Global Antifungal Microbial Drugs Market Size Estimates and Forecasts
1.4.1 Global Antifungal Microbial Drugs Revenue 2020-2031
1.4.2 Global Antifungal Microbial Drugs Sales 2020-2031
1.4.3 Global Antifungal Microbial Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antifungal Microbial Drugs Market Competition by Manufacturers
2.1 Global Antifungal Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antifungal Microbial Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antifungal Microbial Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antifungal Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antifungal Microbial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antifungal Microbial Drugs, Product Type & Application
2.7 Global Key Manufacturers of Antifungal Microbial Drugs, Date of Enter into This Industry
2.8 Global Antifungal Microbial Drugs Market Competitive Situation and Trends
2.8.1 Global Antifungal Microbial Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antifungal Microbial Drugs Players Market Share by Revenue
2.8.3 Global Antifungal Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antifungal Microbial Drugs Market Scenario by Region
3.1 Global Antifungal Microbial Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antifungal Microbial Drugs Sales by Region: 2020-2031
3.2.1 Global Antifungal Microbial Drugs Sales by Region: 2020-2025
3.2.2 Global Antifungal Microbial Drugs Sales by Region: 2026-2031
3.3 Global Antifungal Microbial Drugs Revenue by Region: 2020-2031
3.3.1 Global Antifungal Microbial Drugs Revenue by Region: 2020-2025
3.3.2 Global Antifungal Microbial Drugs Revenue by Region: 2026-2031
3.4 North America Antifungal Microbial Drugs Market Facts & Figures by Country
3.4.1 North America Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antifungal Microbial Drugs Sales by Country (2020-2031)
3.4.3 North America Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antifungal Microbial Drugs Market Facts & Figures by Country
3.5.1 Europe Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antifungal Microbial Drugs Sales by Country (2020-2031)
3.5.3 Europe Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antifungal Microbial Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Antifungal Microbial Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antifungal Microbial Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Antifungal Microbial Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antifungal Microbial Drugs Market Facts & Figures by Country
3.7.1 Latin America Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antifungal Microbial Drugs Sales by Country (2020-2031)
3.7.3 Latin America Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antifungal Microbial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antifungal Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antifungal Microbial Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antifungal Microbial Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antifungal Microbial Drugs Sales by Type (2020-2031)
4.1.1 Global Antifungal Microbial Drugs Sales by Type (2020-2025)
4.1.2 Global Antifungal Microbial Drugs Sales by Type (2026-2031)
4.1.3 Global Antifungal Microbial Drugs Sales Market Share by Type (2020-2031)
4.2 Global Antifungal Microbial Drugs Revenue by Type (2020-2031)
4.2.1 Global Antifungal Microbial Drugs Revenue by Type (2020-2025)
4.2.2 Global Antifungal Microbial Drugs Revenue by Type (2026-2031)
4.2.3 Global Antifungal Microbial Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Antifungal Microbial Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antifungal Microbial Drugs Sales by Application (2020-2031)
5.1.1 Global Antifungal Microbial Drugs Sales by Application (2020-2025)
5.1.2 Global Antifungal Microbial Drugs Sales by Application (2026-2031)
5.1.3 Global Antifungal Microbial Drugs Sales Market Share by Application (2020-2031)
5.2 Global Antifungal Microbial Drugs Revenue by Application (2020-2031)
5.2.1 Global Antifungal Microbial Drugs Revenue by Application (2020-2025)
5.2.2 Global Antifungal Microbial Drugs Revenue by Application (2026-2031)
5.2.3 Global Antifungal Microbial Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Antifungal Microbial Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Company Information
6.1.2 Seres Therapeutics Description and Business Overview
6.1.3 Seres Therapeutics Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seres Therapeutics Antifungal Microbial Drugs Product Portfolio
6.1.5 Seres Therapeutics Recent Developments/Updates
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Company Information
6.2.2 Assembly Biosciences Description and Business Overview
6.2.3 Assembly Biosciences Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Assembly Biosciences Antifungal Microbial Drugs Product Portfolio
6.2.5 Assembly Biosciences Recent Developments/Updates
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Company Information
6.3.2 Synthetic Biologics Description and Business Overview
6.3.3 Synthetic Biologics Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synthetic Biologics Antifungal Microbial Drugs Product Portfolio
6.3.5 Synthetic Biologics Recent Developments/Updates
6.4 Interxon
6.4.1 Interxon Company Information
6.4.2 Interxon Description and Business Overview
6.4.3 Interxon Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Interxon Antifungal Microbial Drugs Product Portfolio
6.4.5 Interxon Recent Developments/Updates
6.5 PureTech
6.5.1 PureTech Company Information
6.5.2 PureTech Description and Business Overview
6.5.3 PureTech Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PureTech Antifungal Microbial Drugs Product Portfolio
6.5.5 PureTech Recent Developments/Updates
6.6 Synlogic
6.6.1 Synlogic Company Information
6.6.2 Synlogic Description and Business Overview
6.6.3 Synlogic Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synlogic Antifungal Microbial Drugs Product Portfolio
6.6.5 Synlogic Recent Developments/Updates
6.7 Enterome BioScience
6.7.1 Enterome BioScience Company Information
6.7.2 Enterome BioScience Description and Business Overview
6.7.3 Enterome BioScience Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enterome BioScience Antifungal Microbial Drugs Product Portfolio
6.7.5 Enterome BioScience Recent Developments/Updates
6.8 4D Pharma
6.8.1 4D Pharma Company Information
6.8.2 4D Pharma Description and Business Overview
6.8.3 4D Pharma Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 4D Pharma Antifungal Microbial Drugs Product Portfolio
6.8.5 4D Pharma Recent Developments/Updates
6.9 Second Genome
6.9.1 Second Genome Company Information
6.9.2 Second Genome Description and Business Overview
6.9.3 Second Genome Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Second Genome Antifungal Microbial Drugs Product Portfolio
6.9.5 Second Genome Recent Developments/Updates
6.10 AOBiome
6.10.1 AOBiome Company Information
6.10.2 AOBiome Description and Business Overview
6.10.3 AOBiome Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AOBiome Antifungal Microbial Drugs Product Portfolio
6.10.5 AOBiome Recent Developments/Updates
6.11 Rebiotix
6.11.1 Rebiotix Company Information
6.11.2 Rebiotix Description and Business Overview
6.11.3 Rebiotix Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rebiotix Antifungal Microbial Drugs Product Portfolio
6.11.5 Rebiotix Recent Developments/Updates
6.12 Metabiomics
6.12.1 Metabiomics Company Information
6.12.2 Metabiomics Description and Business Overview
6.12.3 Metabiomics Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Metabiomics Antifungal Microbial Drugs Product Portfolio
6.12.5 Metabiomics Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Company Information
6.13.2 Ritter Pharmaceuticals Description and Business Overview
6.13.3 Ritter Pharmaceuticals Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ritter Pharmaceuticals Antifungal Microbial Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Symberix
6.14.1 Symberix Company Information
6.14.2 Symberix Description and Business Overview
6.14.3 Symberix Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Symberix Antifungal Microbial Drugs Product Portfolio
6.14.5 Symberix Recent Developments/Updates
6.15 OpenBiome
6.15.1 OpenBiome Company Information
6.15.2 OpenBiome Description and Business Overview
6.15.3 OpenBiome Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 OpenBiome Antifungal Microbial Drugs Product Portfolio
6.15.5 OpenBiome Recent Developments/Updates
6.16 Azitra
6.16.1 Azitra Company Information
6.16.2 Azitra Description and Business Overview
6.16.3 Azitra Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Azitra Antifungal Microbial Drugs Product Portfolio
6.16.5 Azitra Recent Developments/Updates
6.17 Osel
6.17.1 Osel Company Information
6.17.2 Osel Description and Business Overview
6.17.3 Osel Antifungal Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Osel Antifungal Microbial Drugs Product Portfolio
6.17.5 Osel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antifungal Microbial Drugs Industry Chain Analysis
7.2 Antifungal Microbial Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antifungal Microbial Drugs Production Mode & Process Analysis
7.4 Antifungal Microbial Drugs Sales and Marketing
7.4.1 Antifungal Microbial Drugs Sales Channels
7.4.2 Antifungal Microbial Drugs Distributors
7.5 Antifungal Microbial Drugs Customer Analysis
8 Antifungal Microbial Drugs Market Dynamics
8.1 Antifungal Microbial Drugs Industry Trends
8.2 Antifungal Microbial Drugs Market Drivers
8.3 Antifungal Microbial Drugs Market Challenges
8.4 Antifungal Microbial Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Antifungal Microbial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antifungal Microbial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antifungal Microbial Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antifungal Microbial Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Antifungal Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antifungal Microbial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antifungal Microbial Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antifungal Microbial Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antifungal Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antifungal Microbial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antifungal Microbial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Antifungal Microbial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antifungal Microbial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal Microbial Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antifungal Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antifungal Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Antifungal Microbial Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Antifungal Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Antifungal Microbial Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Antifungal Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antifungal Microbial Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Antifungal Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antifungal Microbial Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antifungal Microbial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antifungal Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Antifungal Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Antifungal Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antifungal Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antifungal Microbial Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Antifungal Microbial Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Antifungal Microbial Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Antifungal Microbial Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Antifungal Microbial Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antifungal Microbial Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antifungal Microbial Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Antifungal Microbial Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Antifungal Microbial Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Antifungal Microbial Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Antifungal Microbial Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Antifungal Microbial Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Antifungal Microbial Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Antifungal Microbial Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Antifungal Microbial Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antifungal Microbial Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antifungal Microbial Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Antifungal Microbial Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Antifungal Microbial Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Antifungal Microbial Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seres Therapeutics Company Information
Table 71. Seres Therapeutics Description and Business Overview
Table 72. Seres Therapeutics Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seres Therapeutics Antifungal Microbial Drugs Product
Table 74. Seres Therapeutics Recent Developments/Updates
Table 75. Assembly Biosciences Company Information
Table 76. Assembly Biosciences Description and Business Overview
Table 77. Assembly Biosciences Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Assembly Biosciences Antifungal Microbial Drugs Product
Table 79. Assembly Biosciences Recent Developments/Updates
Table 80. Synthetic Biologics Company Information
Table 81. Synthetic Biologics Description and Business Overview
Table 82. Synthetic Biologics Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Synthetic Biologics Antifungal Microbial Drugs Product
Table 84. Synthetic Biologics Recent Developments/Updates
Table 85. Interxon Company Information
Table 86. Interxon Description and Business Overview
Table 87. Interxon Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Interxon Antifungal Microbial Drugs Product
Table 89. Interxon Recent Developments/Updates
Table 90. PureTech Company Information
Table 91. PureTech Description and Business Overview
Table 92. PureTech Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. PureTech Antifungal Microbial Drugs Product
Table 94. PureTech Recent Developments/Updates
Table 95. Synlogic Company Information
Table 96. Synlogic Description and Business Overview
Table 97. Synlogic Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Synlogic Antifungal Microbial Drugs Product
Table 99. Synlogic Recent Developments/Updates
Table 100. Enterome BioScience Company Information
Table 101. Enterome BioScience Description and Business Overview
Table 102. Enterome BioScience Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Enterome BioScience Antifungal Microbial Drugs Product
Table 104. Enterome BioScience Recent Developments/Updates
Table 105. 4D Pharma Company Information
Table 106. 4D Pharma Description and Business Overview
Table 107. 4D Pharma Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. 4D Pharma Antifungal Microbial Drugs Product
Table 109. 4D Pharma Recent Developments/Updates
Table 110. Second Genome Company Information
Table 111. Second Genome Description and Business Overview
Table 112. Second Genome Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Second Genome Antifungal Microbial Drugs Product
Table 114. Second Genome Recent Developments/Updates
Table 115. AOBiome Company Information
Table 116. AOBiome Description and Business Overview
Table 117. AOBiome Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AOBiome Antifungal Microbial Drugs Product
Table 119. AOBiome Recent Developments/Updates
Table 120. Rebiotix Company Information
Table 121. Rebiotix Description and Business Overview
Table 122. Rebiotix Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Rebiotix Antifungal Microbial Drugs Product
Table 124. Rebiotix Recent Developments/Updates
Table 125. Metabiomics Company Information
Table 126. Metabiomics Description and Business Overview
Table 127. Metabiomics Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Metabiomics Antifungal Microbial Drugs Product
Table 129. Metabiomics Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Antifungal Microbial Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Symberix Company Information
Table 136. Symberix Description and Business Overview
Table 137. Symberix Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Symberix Antifungal Microbial Drugs Product
Table 139. Symberix Recent Developments/Updates
Table 140. OpenBiome Company Information
Table 141. OpenBiome Description and Business Overview
Table 142. OpenBiome Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. OpenBiome Antifungal Microbial Drugs Product
Table 144. OpenBiome Recent Developments/Updates
Table 145. Azitra Company Information
Table 146. Azitra Description and Business Overview
Table 147. Azitra Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Azitra Antifungal Microbial Drugs Product
Table 149. Azitra Recent Developments/Updates
Table 150. Osel Company Information
Table 151. Osel Description and Business Overview
Table 152. Osel Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Osel Antifungal Microbial Drugs Product
Table 154. Osel Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Antifungal Microbial Drugs Distributors List
Table 158. Antifungal Microbial Drugs Customers List
Table 159. Antifungal Microbial Drugs Market Trends
Table 160. Antifungal Microbial Drugs Market Drivers
Table 161. Antifungal Microbial Drugs Market Challenges
Table 162. Antifungal Microbial Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antifungal Microbial Drugs
Figure 2. Global Antifungal Microbial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antifungal Microbial Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Dosage Form Product Picture
Figure 5. Enteric Capsules Product Picture
Figure 6. Global Antifungal Microbial Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Antifungal Microbial Drugs Market Share by Application: 2024 & 2031
Figure 8. Gastrointestinal Disorders
Figure 9. Autoimmune Disorders
Figure 10. Diabetes
Figure 11. Cancer
Figure 12. Others
Figure 13. Global Antifungal Microbial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antifungal Microbial Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Antifungal Microbial Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Antifungal Microbial Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Antifungal Microbial Drugs Report Years Considered
Figure 18. Antifungal Microbial Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Antifungal Microbial Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Antifungal Microbial Drugs Players: Market Share by Revenue in Antifungal Microbial Drugs in 2024
Figure 21. Antifungal Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Antifungal Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Antifungal Microbial Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Antifungal Microbial Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Antifungal Microbial Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Antifungal Microbial Drugs by Type (2020-2031)
Figure 55. Global Antifungal Microbial Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Antifungal Microbial Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Antifungal Microbial Drugs by Application (2020-2031)
Figure 58. Global Antifungal Microbial Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Antifungal Microbial Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Antifungal Microbial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antifungal Microbial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antifungal Microbial Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antifungal Microbial Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Antifungal Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antifungal Microbial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antifungal Microbial Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antifungal Microbial Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antifungal Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antifungal Microbial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antifungal Microbial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Antifungal Microbial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antifungal Microbial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal Microbial Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antifungal Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antifungal Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Antifungal Microbial Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Antifungal Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Antifungal Microbial Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Antifungal Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antifungal Microbial Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Antifungal Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antifungal Microbial Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antifungal Microbial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antifungal Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Antifungal Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Antifungal Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antifungal Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antifungal Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antifungal Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Antifungal Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Antifungal Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antifungal Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antifungal Microbial Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Antifungal Microbial Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Antifungal Microbial Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Antifungal Microbial Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Antifungal Microbial Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antifungal Microbial Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antifungal Microbial Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Antifungal Microbial Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Antifungal Microbial Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Antifungal Microbial Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Antifungal Microbial Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Antifungal Microbial Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Antifungal Microbial Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Antifungal Microbial Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Antifungal Microbial Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antifungal Microbial Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antifungal Microbial Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Antifungal Microbial Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Antifungal Microbial Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Antifungal Microbial Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seres Therapeutics Company Information
Table 71. Seres Therapeutics Description and Business Overview
Table 72. Seres Therapeutics Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seres Therapeutics Antifungal Microbial Drugs Product
Table 74. Seres Therapeutics Recent Developments/Updates
Table 75. Assembly Biosciences Company Information
Table 76. Assembly Biosciences Description and Business Overview
Table 77. Assembly Biosciences Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Assembly Biosciences Antifungal Microbial Drugs Product
Table 79. Assembly Biosciences Recent Developments/Updates
Table 80. Synthetic Biologics Company Information
Table 81. Synthetic Biologics Description and Business Overview
Table 82. Synthetic Biologics Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Synthetic Biologics Antifungal Microbial Drugs Product
Table 84. Synthetic Biologics Recent Developments/Updates
Table 85. Interxon Company Information
Table 86. Interxon Description and Business Overview
Table 87. Interxon Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Interxon Antifungal Microbial Drugs Product
Table 89. Interxon Recent Developments/Updates
Table 90. PureTech Company Information
Table 91. PureTech Description and Business Overview
Table 92. PureTech Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. PureTech Antifungal Microbial Drugs Product
Table 94. PureTech Recent Developments/Updates
Table 95. Synlogic Company Information
Table 96. Synlogic Description and Business Overview
Table 97. Synlogic Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Synlogic Antifungal Microbial Drugs Product
Table 99. Synlogic Recent Developments/Updates
Table 100. Enterome BioScience Company Information
Table 101. Enterome BioScience Description and Business Overview
Table 102. Enterome BioScience Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Enterome BioScience Antifungal Microbial Drugs Product
Table 104. Enterome BioScience Recent Developments/Updates
Table 105. 4D Pharma Company Information
Table 106. 4D Pharma Description and Business Overview
Table 107. 4D Pharma Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. 4D Pharma Antifungal Microbial Drugs Product
Table 109. 4D Pharma Recent Developments/Updates
Table 110. Second Genome Company Information
Table 111. Second Genome Description and Business Overview
Table 112. Second Genome Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Second Genome Antifungal Microbial Drugs Product
Table 114. Second Genome Recent Developments/Updates
Table 115. AOBiome Company Information
Table 116. AOBiome Description and Business Overview
Table 117. AOBiome Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AOBiome Antifungal Microbial Drugs Product
Table 119. AOBiome Recent Developments/Updates
Table 120. Rebiotix Company Information
Table 121. Rebiotix Description and Business Overview
Table 122. Rebiotix Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Rebiotix Antifungal Microbial Drugs Product
Table 124. Rebiotix Recent Developments/Updates
Table 125. Metabiomics Company Information
Table 126. Metabiomics Description and Business Overview
Table 127. Metabiomics Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Metabiomics Antifungal Microbial Drugs Product
Table 129. Metabiomics Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Antifungal Microbial Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Symberix Company Information
Table 136. Symberix Description and Business Overview
Table 137. Symberix Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Symberix Antifungal Microbial Drugs Product
Table 139. Symberix Recent Developments/Updates
Table 140. OpenBiome Company Information
Table 141. OpenBiome Description and Business Overview
Table 142. OpenBiome Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. OpenBiome Antifungal Microbial Drugs Product
Table 144. OpenBiome Recent Developments/Updates
Table 145. Azitra Company Information
Table 146. Azitra Description and Business Overview
Table 147. Azitra Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Azitra Antifungal Microbial Drugs Product
Table 149. Azitra Recent Developments/Updates
Table 150. Osel Company Information
Table 151. Osel Description and Business Overview
Table 152. Osel Antifungal Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Osel Antifungal Microbial Drugs Product
Table 154. Osel Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Antifungal Microbial Drugs Distributors List
Table 158. Antifungal Microbial Drugs Customers List
Table 159. Antifungal Microbial Drugs Market Trends
Table 160. Antifungal Microbial Drugs Market Drivers
Table 161. Antifungal Microbial Drugs Market Challenges
Table 162. Antifungal Microbial Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antifungal Microbial Drugs
Figure 2. Global Antifungal Microbial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antifungal Microbial Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Dosage Form Product Picture
Figure 5. Enteric Capsules Product Picture
Figure 6. Global Antifungal Microbial Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Antifungal Microbial Drugs Market Share by Application: 2024 & 2031
Figure 8. Gastrointestinal Disorders
Figure 9. Autoimmune Disorders
Figure 10. Diabetes
Figure 11. Cancer
Figure 12. Others
Figure 13. Global Antifungal Microbial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antifungal Microbial Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Antifungal Microbial Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Antifungal Microbial Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Antifungal Microbial Drugs Report Years Considered
Figure 18. Antifungal Microbial Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Antifungal Microbial Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Antifungal Microbial Drugs Players: Market Share by Revenue in Antifungal Microbial Drugs in 2024
Figure 21. Antifungal Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Antifungal Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Antifungal Microbial Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Antifungal Microbial Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Antifungal Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Antifungal Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Antifungal Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Antifungal Microbial Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Antifungal Microbial Drugs by Type (2020-2031)
Figure 55. Global Antifungal Microbial Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Antifungal Microbial Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Antifungal Microbial Drugs by Application (2020-2031)
Figure 58. Global Antifungal Microbial Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Antifungal Microbial Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232